20-24 year olds get meningitis C vaccine
The meningitis C immunisation programme is to be extended to millions more young adults in the United Kingdom. The plan was announced after advice from a Commons select committee that meningitis C is twice as common in 20-24 year olds than in the rest of the adult population. Disturbingly, the incidence of group C meningococcal disease has risen by 28% in 20-24 year olds in the past year. The vaccine is anticipated to reduce the occurrence of the disease as it did in children and teenagers.
Since its introduction for those younger than 20 in 1999 the vaccine has had encouraging results. In 2001 the number of meningitis cases was reduced by 90%. Denise Vaughan of the Meningitis Research Foundation said she was “delighted that the government is now making the vaccine available to 20-24 year olds, which will undoubtedly save lives.”
She added, however, “Not all forms of meningitis